Market Overview - The net inflow of main funds in the Shanghai and Shenzhen markets was 307 million yuan, with the Sci-Tech Innovation Board experiencing a net outflow of 512 million yuan [2] - A total of 245 stocks saw net inflows, while 341 stocks experienced net outflows [2] Sci-Tech Innovation Board Performance - On the Sci-Tech Innovation Board, 354 stocks rose and 222 stocks fell today [2] - Newly listed stock C Hanbang closed with a significant increase of 102.46% and a turnover rate of 75.65% [3] Fund Flow Analysis - Among the stocks with net inflows, C Hanbang led with a net inflow of 210 million yuan, followed by Aifute and Hotgen with net inflows of approximately 57.61 million yuan and 47.27 million yuan, respectively [3] - The stock with the highest net outflow was Haiguang Information, which saw a net outflow of 176 million yuan and a decline of 2.43% [2][3] - A total of 49 stocks had continuous net inflows for more than three trading days, with Rui Lian New Materials and Li Yang Chip leading with 10 consecutive days of inflow [3] Key Stocks with Fund Inflows - The top stocks by net inflow include: - C Hanbang: 210.20 million yuan, 34.52% inflow rate, 102.46% increase, 75.65% turnover [3] - Aifute: 57.61 million yuan, 7.81% inflow rate, 1.13% increase, 5.01% turnover [3] - Hotgen: 47.27 million yuan, 7.29% inflow rate, 12.09% increase, 6.60% turnover [3] Key Stocks with Fund Outflows - The stocks with the highest net outflows include: - Haiguang Information: 176 million yuan outflow, 2.43% decrease [2] - Hanwujing: 168 million yuan outflow [2] - Zhongwei Company: 72.16 million yuan outflow [2]

科创50指数今日下跌0.57%，报收995.24点，科创板全日成交量21.53亿股，成交额714.43亿元，加权平 均换手率为1.28%。 证券时报·数据宝统计显示，今日可交易科创板股中，354只股收盘上涨，涨幅超过10%的有3只，涨幅 在5%至10%的有23只，收盘下跌的有222只。 科创板股换手率区间分布显示，换手率超过20%的有3只，换手率10%~20%的有3只，换手率5%~10%的 32只，换手率3%~5%的61只，换手率1%~3%的280只，换手率不足1%的有208只。 换手率最高的是C汉邦，该股为今日上市的新股，收盘涨幅102.46%，换手率75.65%，日成交额6.09亿 元，全天主力资金净流入2.10亿元。其次是航天南湖，该股今日收盘上涨0.67%，全天换手率26.68%， 成交额8.14亿元，换手率居前的还有中研股份、中邮科技、有方科技等，换手率分别为23.05%、 16.08%、13.20%。 资金流向方面，高换手率个股中，有22股今日获主力资金净流入，净流入金额较多的有C汉邦、埃夫 特、热景生物，净流入金额分别为2.10亿元、5760.94万元、4727.49万元，净流出金额较多的有精进 ...

Core Viewpoint - Jiangsu Hanbang Technology Co., Ltd. has successfully listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with a closing price of 46.10 yuan, representing a 102.46% increase on the first day of trading [1] Company Overview - Hanbang Technology focuses on chromatography technology, integrating research and development, production, and sales, primarily serving the pharmaceutical and life sciences sectors with specialized separation and purification equipment, consumables, and technical solutions [1] - The company is controlled by Zhang Dabin, who holds 23.75% of the shares directly and has a total control of 28.94% post-IPO [1] IPO Details - The company issued 22,000,000 shares at a price of 22.77 yuan per share, raising a total of 500.94 million yuan, with a net amount of 430.67 million yuan after deducting issuance costs [4] - The total issuance costs amounted to 70.27 million yuan, with underwriting fees of 37.29 million yuan [6] Financial Performance - For the years 2022 to 2024, the company reported revenues of 481.79 million yuan, 619.01 million yuan, and 690.88 million yuan, respectively, with net profits of 38.56 million yuan, 51.50 million yuan, and 79.34 million yuan [6][7] - In the first quarter of 2025, the company achieved total revenue of 165.23 million yuan, a year-on-year increase of 19.88%, and a net profit of 11.10 million yuan, up 93.79% from the previous year [9][10] Project Funding Allocation - The raised funds will be allocated to three main projects: 1. Annual production of 1,000 units of liquid chromatography separation equipment (19.30 million yuan) 2. Construction of a chromatography separation equipment R&D center (27.11 million yuan) 3. Annual production of 2,000 units of laboratory chromatography separation and purification instruments (22.48 million yuan) [5]

Group 1 - The Sci-Tech 50 Index opened slightly lower on May 16, closing at 995.24 points with a decline of 0.57% and a total trading volume of approximately 17.2 billion [1] - The Sci-Tech Comprehensive Index also opened lower but rose during the day, ultimately closing at 1170.20 points with an increase of 0.12% and a total trading volume of about 71.4 billion [1] - A significant number of stocks on the Sci-Tech Board reached new highs, with 16 stocks hitting their highest levels since 2025, and 36 stocks achieving new highs over the past 30 trading days [1] Group 2 - Hanbang Technology was listed on the Sci-Tech Board on May 16 with a stock code of 688755, and its share price increased by 102.46% on the first day, with a trading volume of approximately 609 million [2] - Excluding Hanbang Technology's first-day performance, the average increase for the remaining 586 stocks on the Sci-Tech Board was 0.70%, with an average turnover rate of 1.97% and a total trading volume of 708.34 billion [2] - In terms of individual stock performance, Hanjing Bio saw the highest increase at 12.09%, while Jingyuan Environmental experienced the largest decline at 9.38% [2] Group 3 - In terms of trading volume, Hanbang Technology led with 2.403 billion, while Conglin Technology had the lowest trading volume at 702.32 million [3] - The turnover rate for Aerospace Nanhu was the highest at 26.68%, while Longteng Optoelectronics had the lowest turnover rate at 0.09% [3]

Company Overview - Jiangsu Hanbang Technology Co., Ltd. was established in 1998 and currently employs over 650 people. It is recognized as a national high-tech enterprise and a "little giant" enterprise specializing in technology [5][8]. - The company focuses on providing professional separation and purification equipment, consumables, application technology services, and related technical solutions for the pharmaceutical and life sciences sectors [7]. Market Performance - On May 16, 2023, Hanbang Technology successfully listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with a stock price of 22.77 yuan per share [3]. - On its first trading day, the stock surged by 115.20%, reaching a price of 49 yuan, resulting in a market capitalization of 4.312 billion yuan. The stock price later exceeded 50 yuan, with a rise of over 120% [4]. Innovation and Recognition - The company has a strong commitment to independent innovation, holding a total of 51 authorized invention patents, including 38 domestic and 13 overseas patents [8]. - Hanbang Technology has led or participated in 15 provincial-level or higher scientific research or industrialization projects, including six national-level projects [8]. Industry Position - Hanbang Technology holds a leading market share in the domestic chromatography separation and purification equipment market and aims to become a mainstream provider of overall solutions for global pharmaceutical companies [8]. - The company serves over 2,000 clients, including well-known domestic pharmaceutical enterprises such as Heng Rui Medicine, Zhengda Tianqing, and international clients from countries like Germany, the UK, India, South Korea, and Norway [8].

Company Overview - N Hanbang has been listed today with an opening price of 49.00 yuan, representing an increase of 115.20% from its issue price [2] - The company focuses on chromatography technology, integrating research and development, production, and sales, primarily serving the pharmaceutical and life sciences sectors with specialized separation and purification equipment, consumables, application technology services, and related technical solutions [2] Financial Highlights - The total number of shares issued by the company is 22 million, with an online issuance of 7.04 million shares at an issue price of 22.77 yuan per share [2] - The issue price corresponds to a price-to-earnings (P/E) ratio of 26.35, compared to the industry average P/E ratio of 28.04 [2] - The total funds raised from the initial public offering (IPO) amount to 501 million yuan, which will be used for working capital, the construction of a chromatography separation equipment R&D center, and the production projects for laboratory chromatography separation and purification instruments [2] Recent IPO Performance - N Hanbang's first-day performance is notable, with a significant increase of 115.20% [2] - Other recent IPOs on the same day include N Zairun, which saw a rise of 98.12%, and Tian Gong Co., which experienced a dramatic increase of 458.63% [3]

Core Viewpoint - Hanbang Technology has successfully transitioned from a chromatography consumables agent to a leading domestic manufacturer of preparative chromatography equipment, becoming the first stock of chromatography equipment on the Sci-Tech Innovation Board [3][4]. Company Development - Established in 1998, Hanbang Technology initially focused on the agency sales of chromatography consumables, facing market saturation by 2006, which prompted a shift towards independent research and development [4]. - The company launched its first dynamic axial compression column in 2005, and by 2012, revenue from self-developed products surpassed that from agency sales [4][5]. - By 2024, Hanbang Technology was recognized as a "little giant" enterprise by the Ministry of Industry and Information Technology, ranking first in the domestic production-grade small molecule liquid chromatography system market [5]. Talent and R&D - Since 2010, Hanbang Technology has focused on attracting and retaining R&D talent, forming a technical team of 141 members by 2024, including 5 core technical personnel [5]. - The company implements various incentive measures, such as salary bonuses and stock options, to stabilize and develop its core technical team [5]. Market Position and Clientele - Hanbang Technology primarily serves the pharmaceutical industry, with notable clients including domestic giants like Heng Rui Medicine and international pharmaceutical equipment integrators [6][7]. - The company emphasizes the importance of high-purity separation and purification technologies, which are increasingly demanded due to stringent regulatory requirements [7]. Business Model and Solutions - Hanbang Technology adopts a dual approach of product development and customized turnkey services, offering solutions for both small and large molecule drug separation and purification [7]. - The company provides tailored solutions based on client sample characteristics, optimizing chromatography filler performance to reduce production costs [7]. Financial Performance - The company's revenue has shown consistent growth, with figures of 482 million yuan, 619 million yuan, and 691 million yuan from 2022 to 2024, respectively [8]. - Net profit attributable to the parent company has also increased, reaching approximately 79.34 million yuan in 2024 [8]. Future Outlook - Hanbang Technology anticipates continued growth in the domestic liquid chromatography market, with the laboratory liquid chromatography market projected to reach 3.6 billion yuan by 2026 [8]. - The company plans to raise funds through an IPO to enhance production capacity and R&D capabilities, with specific projects aimed at increasing production of chromatography equipment and laboratory instruments [8][9]. - Future technical focuses include optimizing chromatography system pressure resistance, fluid distribution, sealing, and homogenization technologies, as well as developing higher selectivity chromatography materials [9].

江苏汉邦科技股份有限公司 首次公开发行股票科创板 上市公告书提示性公告 保荐人（主承销商）：中信证券股份有限公司 扫描二维码查阅公告全文 本公司及全体董事、监事、高级管理人员保证信息披露的内容真实、准确、 完整、及时，没有虚假记载、误导性陈述或重大遗漏。 经上海证券交易所审核同意，江苏汉邦科技股份有限公司（以下简称"汉邦 科技"、"公司"、"本公司"或"发行人"）发行的人民币普通股股票将于 2025 年 5 月 16 日在上海证券交易所科创板上市，上市公告书全文和首次公开发行股 票的招股说明书在上海证券交易所网站（http://www.sse.com.cn/）和符合中国证 监 会 规 定 条 件 网 站 （ 中 国 证 券 网 ， http://www.cnstock.com ； 中 证 网 ， http://www.cs.com.cn ； 证 券 时 报 网 ， http://www.stcn.com ； 证 券 日 报 网 ， http://www.zqrb.cn）披露，并置备于发行人、上交所、本次发行保荐人（主承销 商）中信证券股份有限公司的住所，供公众查阅。 一、上市概况 （一）股票简称：汉邦科技 （ ...

股票简称：汉邦科技 股票代码：688755 江苏汉邦科技股份有限公司 Jiangsu Hanbon Science and Technology Co., Ltd. （淮安经济技术开发区新竹路 10 号；淮安经济技术开发区集贤路 1-9 号） 首次公开发行股票科创板上市公告书 保荐人（主承销商） 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 二〇二五年五月十五日 江苏汉邦科技股份有限公司 上市公告书 特别提示 江苏汉邦科技股份有限公司（以下简称"汉邦科技"、"本公司"、"发 行人"、"公司"）股票将于 2025 年 5 月 16 日在上海证券交易所科创板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在 新股上市初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 1 江苏汉邦科技股份有限公司 上市公告书 第一节 重要声明与提示 一、重要声明与提示 本公司及全体董事、监事、高级管理人员保证上市公告书所披露信息的真 实、准确、完整，承诺上市公告书不存在虚假记载、误导性陈述或重大遗漏， 并依法承担法律责任。 上海证券交易所、有关政府机关对本公司股票上市及有关事项的意见，均 不表明 ...

江苏汉邦 日限公 (草案) 2023年 4月 4-2-1 t and the | 第一章 | 总 则 | | --- | --- | | 第二章 | 经营宗旨和范围 | | 第三章 | 股 价 | | 第四章 | 股东和股东大会 . | | 第五章 | 董事会 ……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………23 | | 第六章 | 总经理及其他高级管理人员 . | | 第七章 | 业事公 ………………………………………………………………………………………………………………35 | | 第八章 | 财务会计制度、利润分配和审计 . | | 第九章 | 通知和公告 | | 第十章 | 合并、分立、增资、减资、解散和清算 | | | 第十一章 修改章程. | | | 第十二章 附 则 ……………………………………………………………………………………………………………………………………………………………………………………… ...